Search

What Interests You?

Search
Advertisement
The page you were looking for no longer exists. The following search results may be of interest.
Benlysta®: Moderate to Severe Lupus Drug Nearing FDA Approval Article 
Lupus treatment has not had an FDA approved drug in over 40 years. Learn about the actions, uses and side effects of Benlysta® as it nears FDA approval.
Jul 23, 2010 - Katrin Holt
Proteomics: Making Use of the Human Genome Article 
Proteomics, the study of proteins, is an extension of genomics. It recognises the significant role proteins play in all cellular activities.
May 14, 2010 - Zoe Bianchi
New Lupus Drug Article 
Patients with systemic lupus erythematosus (SLE) can anticipate new treatment made possible by promising research in the field of biotechnology.
Nov 3, 2009 - Sara E. Lewis
Lupus Patients Celebrate Approval of Beimumab Article 
The therapeutic antibody belimumab (Benlysta) is the first approved monoclonal antibody therapy for the autoimmune disorder systemic lupus erythematosus.
Mar 18, 2011 - Elaine Moore
Emerging Cancer Therapies Prove Profitable Article 
Patients soon will benefit from the advances that have occurred from DNA profiling and the emerging field of pharmacogenomics, according to experts in the field.
Jan 25, 2010 - Louise Harris
Genetic Modification Food Facts Article 
This article describes what genetically modified foods are, statistics regarding the use of, and the origins, health concerns, and benefits of genetically modified foods.
Jun 2, 2008 - Ellen Wilson